Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed optimally titrated pramipexole, with significantly reduced sleep-related and dopaminergic side effectsData analysis also confirmed patients treated with P2B001 developed significantly less new-onset excessive daytime sleepiness when compared to marketed pramipexole
Pharma Two B to Present Additional Positi... - Cure Parkinson's
Pharma Two B to Present Additional Positive Results from P2B001 Phase 3 Trial at 2023 American Academy of Neurology Annual Meeting
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
What is considered a high dose of madopar ?
I am on 125 mg x 2 madopar 3 times a day and 0.7 mg of pramipexole 3 times a day , is the madopar...
Benfotiamine In The Mix For PD Again?
The following new animal study (December 2023) suggests that the fat soluble form of vitamin B1,...
Finding the Right Dose of Levodopa
Hello, everyone. I am having a problem trying to find the right dose of Carbidopa/Levodopa 25/100....
What is your experience with Pramipexole?
My husband was diagnosed almost a year ago (at age 55) and we have tried alternative options for...
Melatonin For Cancer
I have passingly mentioned the use of melatonin for cancer. Here is a new review of meta analysis'...
crying out loud for help..
Weaning off Pramipexole 
Xanthohumol and Beer
Supplements and leukopenia (low white blood cell counts)
MAOI for depression in Parkinson’s 
